05th week of 2022 patent applcation highlights part 27 |
Patent application number | Title | Published |
20220033362 | SYNTHETIC METHOD AND APPLICATION OF 2-HYDROXYPHENYL-5-PYRAZINYL KETONE | 2022-02-03 |
20220033363 | HERBICIDALLY ACTIVE SUBSTITUTED PHENYLPYRIMIDINE HYDRAZIDES | 2022-02-03 |
20220033364 | INSECTICIDAL COMPOUNDS | 2022-02-03 |
20220033365 | PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST | 2022-02-03 |
20220033366 | COMPOUNDS USEFUL FOR TREATMENT OR PREVENTION OF MUSCULAR DYSTROPHY AND DERIVATIVES FOR TREATMENT, AMELIORATION OR PREVENTION OF MUSCULAR DYSTROPHY IN MEDICINAL USE THEREOF | 2022-02-03 |
20220033367 | PRODRUGS OF 4-((1R, 3S)-6-CHLORO-3-PHENYL-2,3-DIHYDRO-1H-INDEN-1-Y)-1-,2,2-TRIMETHYLPIPERAZIN- E AND 4-((1R,3S)-6-CHLORO-3-(PHENYL-D5)-2,3-DIHYDRO-1H-INDEN-1YL)-2,2-DIME- THYL-1 (METHYL-D3)PIPERAZINE | 2022-02-03 |
20220033368 | METHOD FOR MAKING PROPENAMIDE COMPOUND | 2022-02-03 |
20220033369 | HYDROXAMIC ACID DERIVATIVE, METHOD FOR PRODUCING SAME AND USE THEREOF | 2022-02-03 |
20220033370 | FUNCTIONALIZED A- ANGELICA LACTONE MONOMERS AND POLYMERS OBTAINED THEREFROM | 2022-02-03 |
20220033371 | DP ANTAGONIST | 2022-02-03 |
20220033372 | METHODS AND COMPOSITIONS RELATING TO GENOTOXIN COLIBACTIN | 2022-02-03 |
20220033373 | METHODS FOR SELECTIVE AROMATIZATION OF CANNABINOIDS | 2022-02-03 |
20220033374 | SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS | 2022-02-03 |
20220033375 | NOVEL CONFORMATIONALLY-RESTRICTED ANALOGUES OF SORAFENIB AND REGORAFENIB AS SELECTIVE KINASE INHIBITORS FOR CANCER TREATMENT | 2022-02-03 |
20220033376 | ESTROGEN RECEPTOR ANTAGONIST | 2022-02-03 |
20220033377 | Chemical Process for the Synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)qu- inazoline | 2022-02-03 |
20220033378 | NOVEL N-(ISOPROPYL-TRIAZOLYL)PYRIDINYL)-HETEROARYL-CARBOXAMIDE DERIVATIVES AND USE THEREOF | 2022-02-03 |
20220033379 | NOVEL COMPOUNDS AS NADPH OXIDASE INHIBITORS | 2022-02-03 |
20220033380 | POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS | 2022-02-03 |
20220033381 | 3-AZABICYCLO[3,1,1]HEPTANE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | 2022-02-03 |
20220033382 | Prodigiosin Analogs And Methods Of Use | 2022-02-03 |
20220033383 | FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS | 2022-02-03 |
20220033384 | DIARYL-AZOLE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISM | 2022-02-03 |
20220033385 | ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS | 2022-02-03 |
20220033386 | 1, 3-DIOXOLANE DERIVATIVE | 2022-02-03 |
20220033387 | 2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF | 2022-02-03 |
20220033388 | HDAC1,2 Inhibitors | 2022-02-03 |
20220033389 | INSECTICIDAL COMPOUNDS | 2022-02-03 |
20220033390 | Novel (isopropyl-triazolyl)pyridinyl-substituted benzooxazinone or benzothiazinone derivatives and use thereof | 2022-02-03 |
20220033391 | SOLID FORM, CRYSTALLINE FORM, AND CRYSTAL FORM A OF FXR AGONIST, AND PREPARATION METHOD AND APPLICATION THEREOF | 2022-02-03 |
20220033392 | AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS | 2022-02-03 |
20220033393 | Compounds for Treating Cannabinoid Toxicity and Acute Cannabinoid Overdose | 2022-02-03 |
20220033394 | COMPOUNDS FOR THE TREATMENT OF PAIN | 2022-02-03 |
20220033395 | INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES | 2022-02-03 |
20220033396 | FURTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV | 2022-02-03 |
20220033397 | PHARMACEUTICAL COMPOUNDS AND THEIR USE AS INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 19 (USP19) | 2022-02-03 |
20220033398 | FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF | 2022-02-03 |
20220033399 | PYRROLOPYRIDINE-ANILINE COMPOUNDS FOR TREATMENT OF DERMAL DISORDERS | 2022-02-03 |
20220033400 | ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOF | 2022-02-03 |
20220033401 | AMPK ACTIVATORS | 2022-02-03 |
20220033402 | MACROCYCLIC INHIBITORS OF ALK, TRKA, TRKB, AND ROS1 | 2022-02-03 |
20220033403 | PYRROLOTRIAZINONES AND IMIDAZOTRIAZINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | 2022-02-03 |
20220033404 | TREATMENT OF INFECTIONS OF TOXOPLASMA GONDII AND CLOSELY RELATED PARASITES | 2022-02-03 |
20220033405 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING PLK1 INHIBITOR AS ACTIVE INGREDIENT | 2022-02-03 |
20220033406 | CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS | 2022-02-03 |
20220033407 | N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of Disease | 2022-02-03 |
20220033408 | PROCESS FOR PREPARING SPIRO DERIVATIVES | 2022-02-03 |
20220033409 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | 2022-02-03 |
20220033410 | SYNTHESIS OF NANOTUBULAR MOLECULES | 2022-02-03 |
20220033411 | A PROCESS FOR PREPARING AN OPTICALLY ACTIVE CINEOLE DERIVATIVE | 2022-02-03 |
20220033412 | 6-HYDROXY-8-OXATRICYCLO[3.2.1.02,4]OCTANE-2-CARBOXAMIDE DERIVATIVES FOR INDUCING CHONDROGENESIS FOR TREATING JOINT DAMAGE | 2022-02-03 |
20220033413 | NEW COMPOUND DERIVED FROM STREPTOMYCES AND USE THEREOF | 2022-02-03 |
20220033414 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | 2022-02-03 |
20220033415 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT INCLUDING SAME | 2022-02-03 |
20220033416 | COMPOUNDS USEFUL TO TREAT INFLUENZA VIRUS INFECTIONS | 2022-02-03 |
20220033417 | THERAPEUTIC AGENTS AND USES THEREOF | 2022-02-03 |
20220033418 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | 2022-02-03 |
20220033419 | FURO[3,4-B]PYRROLE-CONTAINING BTK INHIBITOR | 2022-02-03 |
20220033420 | ORGANIC ELECTROLUMINESCENT MATERIAL AND APPLICATION THEREOF IN OPTOELECTRONIC DEVICES | 2022-02-03 |
20220033421 | ORGANIC ELETROLUMINESCENT MATERIAL, PREPARATION METHOD THEREOF AND ORGANIC ELETROLUMINESCENT DEVICE | 2022-02-03 |
20220033422 | DITERMINALLY SILANOL-MODIFIED PERFLUOROPOLYETHER COMPOUND AND PREPARATION THEREOF | 2022-02-03 |
20220033423 | IONIC LIQUIDS CONTAINING QUATERNARY AMMONIUM AND PHOSPHONIUM CATIONS, AND THEIR USE AS ENVIRONMENTALLY FRIENDLY LUBRICANT ADDITIVES | 2022-02-03 |
20220033424 | FLUOROUS METAL CHELATES COMPOSITIONS | 2022-02-03 |
20220033425 | METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARATION THEREOF | 2022-02-03 |
20220033426 | Transition Metal Macrocyclics as MRI Contrast Agents for Molecular Imaging | 2022-02-03 |
20220033427 | NEUTRAL GLYCOSYLATED AMIDES AND DIANIONIC GLUCURONIDATED ACIDS AS STABILIZERS FOR BIOLOGICAL MOLECULES | 2022-02-03 |
20220033428 | LARGE SCALE PREPARATION OF PSEUDO-TRISACCHARIDE AMINOGLYCOSIDES AND OF INTERMEDIATES THEREOF | 2022-02-03 |
20220033429 | MITHRAMYCIN DERIVATIVES HAVING INCREASED SELECTIVITY AND ANTI-CANCER ACTIVITY | 2022-02-03 |
20220033430 | ORALLY ACTIVE PRODRUG OF GEMCITABINE | 2022-02-03 |
20220033431 | Cyclic Di-Nucleotide Compounds as STING Agonists | 2022-02-03 |
20220033432 | ANTI-HEPATITIS B VIRUS AGENT | 2022-02-03 |
20220033433 | PROCESS FOR PREPARING NUCLEOSIDE PRODRUGS | 2022-02-03 |
20220033434 | ANDROGEN RECEPTOR NUCLEIC ACIDS AND USES THEREOF | 2022-02-03 |
20220033435 | Cyclic Di-Nucleotide Compounds as STING Agonists | 2022-02-03 |
20220033436 | DERIVATIVE OF SARSASAPOGENIN, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2022-02-03 |
20220033437 | ANTI-MICROBIAL PEPTIDES | 2022-02-03 |
20220033438 | NOVEL TUMOR-SPECIFIC POLYPEPTIDE AND USE THEREOF | 2022-02-03 |
20220033439 | PEPTIDE TARGETING MYCOBACTERIUM TUBERCULOSIS TOXIN-ANTITOXIN SYSTEM AND USE THEREOF | 2022-02-03 |
20220033440 | AN IMPROVED PROCESS FOR THE PREPARATION OF PLECANATIDE | 2022-02-03 |
20220033441 | LAG3 Binding Peptides | 2022-02-03 |
20220033442 | SELF-ASSEMBLING PEPTIDE COMPOSITIONS | 2022-02-03 |
20220033443 | PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES | 2022-02-03 |
20220033444 | Cyclic Peptides, Methods of Synthesis, and Methods of Treatment | 2022-02-03 |
20220033445 | METHOD FOR PRODUCING AN ANTITUMORAL ARENAVIRUS AS WELL AS ARENAVIRUS MUTANTS | 2022-02-03 |
20220033446 | SYSTEMS AND METHODS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES | 2022-02-03 |
20220033447 | ENGINEERED BOTULINUM NEUROTOXIN | 2022-02-03 |
20220033448 | METHODS FOR AGGREGATION OF PROTEINS | 2022-02-03 |
20220033449 | IDENTIFICATION OF CHANNELRHODOPSIN-2 (CHR2) MUTATIONS AND METHODS OF USE | 2022-02-03 |
20220033450 | VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF | 2022-02-03 |
20220033451 | SELF-ASSEMBLY OF PROTEIN-BASED BIOMATERIALS WITH MULTIPLE MORPHOLOGIES | 2022-02-03 |
20220033452 | POLYPEPTIDE DERIVED FROM CAP1 AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS EFFECTIVE INGREDIENT | 2022-02-03 |
20220033453 | HEPATOCYTE GROWTH FACTOR FRAGMENTS THAT FUNCTION AS POTENT MET RECEPTOR AGONISTS AND ANTAGONISTS | 2022-02-03 |
20220033454 | INTERLEUKIN-22 FUSION PROTEINS, AND THEIR PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS | 2022-02-03 |
20220033455 | IL-15-BASED FUSIONS TO IL-7 AND IL-21 | 2022-02-03 |
20220033456 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | 2022-02-03 |
20220033457 | TREATMENT OF NEUROLOGICAL DISEASES | 2022-02-03 |
20220033458 | HIGH AFFINITY CELL RECEPTOR FOR RECOGNIZING AFP ANTIGEN | 2022-02-03 |
20220033459 | Chimeric T Cell Receptors, Nucleic Acids, And Methods Of Making And Using The Same | 2022-02-03 |
20220033460 | IDENTIFICATION AND USE OF T CELL EPITOPES IN DESIGNING DIAGNOSTIC AND THERAPEUTIC APPROACHES FOR COVID-19 | 2022-02-03 |
20220033461 | ANTIGEN RECEPTORS AND USES THEREOF | 2022-02-03 |